If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica ...

Kondru joined the Emmes Group in 2024 and most recently served as CEO of Veridix, the company’s AI, technology, and data ...

Boehringer Ingelheim’s Jascayd (nerandomilast) tablets have been granted marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with idiopathic ...

Imfinzi is approved in the US, EU, Japan, China and many other countries around the world as the standard-of-care treatment ...

Join Impetus Digital's pharma-exclusive webinar to discover how compliant AI tools and virtual workflows can elevate static ...

The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases ...

That plurality matters because the strongest answer rarely comes from one point of view, but from several being tested ...

At eight years of follow-up, results showed that Tagrisso continued to show an OS benefit, reducing the risk of death ...

Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to ...

Avalere Health was the night’s most awarded agency, with Novo Nordisk, Roche and The Urology Foundation topping the client ...

Frontera Global, a behavioural intelligence consultancy that connects research, strategy and medical communications to help ...

Novo Nordisk has appointed George Godfrey as Senior Director for Medical and Regulatory in the UK. Godfrey brings over twenty ...